Johnson & Johnson announced that its Tecvayli® combined with Darzalex Faspro® treatment regimen has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory multiple myeloma patients.
Show original
This approval is significant because it provides patients with a potentially new standard of care, which can even be used early in the second-line treatment stage of the disease.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreIn a recently completed equity acquisition transaction, Allen Family Capital disclosed that it actually holds approximately 10.7% of the outstanding common shares of Starz Entertainment Corporation through affiliates.
According to the latest filing with the U.S. Securities and Exchange Commission (SEC), Sky Quarry Inc has officially submitted an amendment to its corporate charter.
Crypto prices
MoreBitcoin
BTC
$71,202.68
-2.86%
Ethereum
ETH
$2,080.07
-3.46%
Tether USDt
USDT
$1
-0.01%
BNB
BNB
$647.22
-2.02%
XRP
XRP
$1.4
-3.00%
USDC
USDC
$1.0000
+0.02%
Solana
SOL
$89.05
-3.38%
TRON
TRX
$0.2845
-1.11%
Dogecoin
DOGE
$0.09375
-8.33%
Cardano
ADA
$0.2687
-4.30%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now